Skip to main content
ISU Abxis Co., Ltd. logo

ISU Abxis Co., Ltd. — Investor Relations & Filings

Ticker · 086890 ISIN · KR7086890001 KO Manufacturing
Open in API
Filings indexed 276 across all filing types
Latest filing 2025-11-04 Regulatory Filings
Country KR South Korea
Listing KO 086890

About ISU Abxis Co., Ltd.

https://www.abxis.com/eng/index.do

ISU Abxis is a biopharmaceutical company specializing in the research and development of innovative biomedicines, primarily engineered antibody-based immunotherapies. Founded in 2001, the company leverages genetic recombination technology to create novel treatments. Its pipeline is focused on addressing significant unmet medical needs in oncology and rare diseases. Key development programs include therapeutics for cancers like Head and Neck Squamous Cell Carcinoma (ISU104) and treatments for rare genetic disorders such as Fabry disease (Fabagal). The company is dedicated to developing advanced antibody-based therapeutics to improve the quality of life for patients with difficult-to-treat conditions.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Regulatory Filings
2025-11-04 Korean
기업설명회(IR)개최
Regulatory Filings
2025-09-22 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a short announcement regarding the scheduling and logistics of an upcoming Investor Relations (IR) meeting (기업설명회). It provides details such as date, location, target audience, and purpose, but does not contain the actual presentation content itself. According to the 'Menu vs Meal' rule, an announcement of an event or report is classified as a Regulatory Filing (RNS) when it does not fit into more specific categories like RPA (which is typically for report publication). Since this is a standard regulatory notification of an IR event, RNS is the appropriate classification.
2025-09-08 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, target audience, and purpose of the meeting. It does not contain the actual presentation slides or financial data, but rather serves as a notification of the event's occurrence. Under the 'Menu vs Meal' rule, this is an announcement of an event/report, fitting the criteria for a Regulatory Filing (RNS) as it is a standard corporate disclosure of an IR activity.
2025-08-22 Korean
반기보고서 (2025.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-Annual Report) for ISU Abxis Co., Ltd. for the period ending June 30, 2025. It contains comprehensive financial information, business overviews, capital changes, and management discussions, which are characteristic of an interim financial report. It is not an announcement of a report, but the report itself. H1 2025
2025-08-14 Korean
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a short announcement regarding an upcoming Investor Relations (IR) meeting (기업설명회). It provides details such as the date, location, purpose, and contact information for the event. It does not contain the actual presentation materials or financial results, but rather announces the scheduling of the event. According to the 'Menu vs Meal' rule, an announcement of an event or report is classified as a Regulatory Filing (RNS) when it does not fit into more specific categories like RPA (which is typically for report publication). Given the nature of the announcement, RNS is the most appropriate fallback category.
2025-08-11 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.